Faculty of Medicine, Institute for Occlusion and Orofacial Pain, University of Coimbra, Coimbra, Portugal.
Postgraduate Program in Medicine (Radiology), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
PLoS One. 2022 Apr 28;17(4):e0267722. doi: 10.1371/journal.pone.0267722. eCollection 2022.
Temporomandibular Disorder (TMD) is a generic term applied to describe musculoskeletal disorders that affect the temporomandibular joint (TMJ), the masticatory muscles and the related structures. TMD comprises two groups of disorders, namely intra-articular TMD and masticatory muscle disorders. There is still difficulty in establishing the effectiveness of different therapeutic modalities for TMD with robust evidence, despite the large volume of publications in the area. The lack of outcomes standardization may represent a limiting factor in the search for scientific evidence.
This study aims to develop a core outcome sets (COS) for clinical trials in intra-articular TMD and masticatory muscle disorders.
The protocol for determining the COS-TMD will consist of three phases: 1. Synthesis of TMD Management Intervention Outcomes. The identification of outcomes will be carried out through a systematic review, which will include randomized clinical trials that evaluated the effectiveness of interventions used in TMD management. 2. Through a two-round international Delphi survey, the list of outcomes will be scored by three panels of stakeholders. 3. A representative sample of key stakeholders will be invited to participate in a face-to-face meeting where they can discuss the results of the Delphi survey and determine the final core set.
The implementation of this protocol will determine the COS-TMD, which will be made available for use in all TMD clinical studies. The use of COS when planning and reporting TMD clinical trials will reduce the risk of publication bias and enable proper comparison of results found by different studies.
颞下颌关节紊乱(TMD)是一个通用术语,用于描述影响颞下颌关节(TMJ)、咀嚼肌和相关结构的肌肉骨骼疾病。TMD 包括两类疾病,即关节内 TMD 和咀嚼肌疾病。尽管该领域已有大量出版物,但仍难以用强有力的证据确定 TMD 不同治疗方法的有效性。缺乏结局标准化可能是寻找科学证据的一个限制因素。
本研究旨在为关节内 TMD 和咀嚼肌疾病的临床试验制定核心结局集(COS)。
确定 COS-TMD 的方案将包括三个阶段:1. TMD 管理干预结局的综合。通过系统评价确定结局,其中将包括评估 TMD 管理中使用的干预措施有效性的随机临床试验。2. 通过两轮国际 Delphi 调查,由三个利益相关者小组对结局清单进行评分。3. 将邀请一组有代表性的关键利益相关者参加面对面会议,讨论 Delphi 调查的结果,并确定最终核心集。
本方案的实施将确定 COS-TMD,可供所有 TMD 临床研究使用。在规划和报告 TMD 临床试验时使用 COS 将降低发表偏倚的风险,并能够对不同研究发现的结果进行适当比较。